These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 12644073)

  • 1. Tacrolimus-induced hemolytic uremic syndrome case presentation in a lung transplant recipient.
    Shitrit D; Starobin D; Aravot D; Fink G; Izbicki G; Kramer M
    Transplant Proc; 2003 Mar; 35(2):627-8. PubMed ID: 12644073
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful use of cyclosporine in a lung transplant recipient with tacrolimus-associated hemolytic uremic syndrome.
    Myers JN; Shabshab SF; Burton NA; Nathan SD
    J Heart Lung Transplant; 1999 Oct; 18(10):1024-6. PubMed ID: 10561115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tacrolimus (FK 506)-induced hemolytic uremic syndrome after heart transplantation.
    Walder B; Ricou B; Suter PM
    J Heart Lung Transplant; 1998 Oct; 17(10):1004-6. PubMed ID: 9811409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tacrolimus-associated hemolytic uremic syndrome in a pediatric heart transplant recipient.
    Gray JM; Ameduri RK
    Pediatr Transplant; 2016 Sep; 20(6):866-7. PubMed ID: 27371345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-renal transplant hemolytic uremic syndrome following combination therapy with tacrolimus and everolimus.
    Pratap B; Abraham G; Srinivas CN; Bhaskar S
    Saudi J Kidney Dis Transpl; 2007 Nov; 18(4):609-12. PubMed ID: 17951952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tacrolimus (FK506) associated thrombotic thrombocytopenic purpura/hemolytic uremic syndrome in lung transplant salvage with a plasmapheresis and cyclosporin.
    Boctor FN
    Egypt J Immunol; 2006; 13(2):95-9. PubMed ID: 18689275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemolytic-uremic syndrome in association with both cyclosporine and tacrolimus.
    Abraham KA; Little MA; Dorman AM; Walshe JJ
    Transpl Int; 2000; 13(6):443-7. PubMed ID: 11140243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. De novo tacrolimus- associated hemolytic uremic syndrome after renal transplantation - case report.
    Neto P; Lopes K; Macário F; Alves R; Mota A; Campos M
    Nefrologia; 2013 Jan; 33(1):152-4. PubMed ID: 23364650
    [No Abstract]   [Full Text] [Related]  

  • 9. Dangerous drug interactions leading to hemolytic uremic syndrome following lung transplantation.
    Parissis H; Gould K; Dark J
    J Cardiothorac Surg; 2010 Sep; 5():70. PubMed ID: 20813025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemolytic-uremic syndrome in a renal transplant recipient on FK 506 immunosuppression.
    Schmidt RJ; Venkat KK; Dumler F
    Transplant Proc; 1991 Dec; 23(6):3156-7. PubMed ID: 1721390
    [No Abstract]   [Full Text] [Related]  

  • 11. Development of transplant renal artery thrombosis and signs of haemolytic-uraemic syndrome following the change from cyclosporin to tacrolimus in a renal transplant patient.
    Kiykim AA; Ozer C; Yildiz A; Tiftik N; Senli M; Kelebek E; Doruk E; Akbay E
    Nephrol Dial Transplant; 2004 Oct; 19(10):2653-6. PubMed ID: 15388824
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hemolytic uremic syndrome due to sirolimus in a heart transplant recipient. Case report].
    Izquierdo MT; Almenar L; Martínez-Dolz L; Moro JA
    Rev Esp Cardiol; 2007 Jan; 60(1):85-6. PubMed ID: 17288963
    [No Abstract]   [Full Text] [Related]  

  • 13. Tacrolimus-induced hemolytic uremic syndrome and end-stage renal failure after liver transplantation.
    Rerolle JP; Akposso K; Lerolle N; Mougenot B; Ponnelle T; Rondeau E; Sraer JD
    Clin Transplant; 2000 Jun; 14(3):262-5. PubMed ID: 10831087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rescue treatment for cyclosporine-associated hemolytic-uremic syndrome with intravenous immunoglobulin.
    Wen YK; Chen ML
    Clin Nephrol; 2006 Jul; 66(1):58-62. PubMed ID: 16878437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haemolytic-uraemic syndrome after tacrolimus rescue therapy for cortisone-resistant rejection.
    Schmidt RH; Lenz T; Gröne HJ; Geiger H; Scheuermann EH
    Nephrol Dial Transplant; 1999 Apr; 14(4):979-83. PubMed ID: 10328486
    [No Abstract]   [Full Text] [Related]  

  • 16. [De novo hemolytic uremic syndrome in a kidney-pancreas recipient in the postoperative period].
    Gutiérrez de la Fuente C; Sola E; Alférez MJ; Navarro A; Cabello M; Burgos D; González Molina M
    Nefrologia; 2004; 24 Suppl 3():3-6. PubMed ID: 15219059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemolytic uremic syndrome after renal transplantation: immunosuppressive therapy with rapamycin.
    Heering P; Deppe CE; Farokhzad F; Helmchen U; Grabensee B
    Nephron; 2002 May; 91(1):177. PubMed ID: 12021541
    [No Abstract]   [Full Text] [Related]  

  • 18. The successful use of tacrolimus (FK506) in a pancreas/kidney transplant recipient with recurrent cyclosporine-associated hemolytic uremic syndrome.
    Kaufman DB; Kaplan B; Kanwar YS; Abecassis M; Stuart FP
    Transplantation; 1995 Jun; 59(12):1737-9. PubMed ID: 7541579
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of cyclosporin-induced haemolytic uraemic syndrome with FK506.
    McCauley J; Bronsther O; Fung J; Todo S; Starzl TE
    Lancet; 1989 Dec 23-30; 2(8678-8679):1516. PubMed ID: 2481200
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical outcome after conversion to FK 506 (tacrolimus) therapy for acute graft-versus-host disease resistant to cyclosporine or for cyclosporine-associated toxicities.
    Furlong T; Storb R; Anasetti C; Appelbaum FR; Deeg HJ; Doney K; Martin P; Sullivan K; Witherspoon R; Nash RA
    Bone Marrow Transplant; 2000 Nov; 26(9):985-91. PubMed ID: 11100278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.